Themis Medicare commences supply of Diclofenac Sodium injection to Novartis

05 Nov 2014 Evaluate

Themis Medicare has commenced the supply of Diclofenac Sodium 75 mg per ml Injection as finished dosage pharmaceutical form to Novartis India with effect from October, 2014. The company had earlier on August 16, 2013 executed a Supply & Distribution Agreement with Novartis India for the same.

Themis Medicare is also engaged in supplying its research formulations to well known Pharmaceutical companies in India namely Alkem Lab, Fulford, Intas Pharmaceuticals, IPCA Lab, Cadila Healthcare, Aristo Pharma, Mankind Pharma, Shreya Lifesciences, Nicholas Piramal, Unichem Lab, etc.

Themis Medicare Share Price

70.55 -4.99 (-6.61%)
23-Mar-2026 15:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1758.75
Dr. Reddys Lab 1251.00
Cipla 1222.05
Zydus Lifesciences 862.00
Lupin 2293.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×